Advertisement
UCB SA

UCB SA (UCBJY) Stock Overview

Explore UCB SA’s financial performance, market position, analyst ratings, and future outlook.

UCBJYPNK
HealthcareBiotechnology
$158.72
$0.85(0.54%)
U.S. Market opens in 5h 52m
Advertisement

UCB SA (UCBJY)

Meyka AI Score

Z

Key Financials

Market Cap60.3B
P/E Ratio33.58
EPS (TTM)$4.63
ROE0.15%
Fundamental Analysis

AI Price Forecasts

1 Month$125.82
3 Months$158.02
1 Year Target$179.52

UCBJY Stock Analysis & Investment Overview

Our comprehensive AI-powered analysis of UCB SA (UCBJY) provides investors with deep insights into the stock's performance, growth potential, and market positioning. With a Meyka AI Score of B+, this stock demonstrates moderate investment characteristics based on our advanced machine learning models.

The current technical analysis reveals key indicators including an RSI of 70.53, suggesting the stock is in an overbought condition. Our forecasting models predict significant price movements, with a 12-month target of $179.52.

Key financial metrics showcase the company's fundamental strength, including a P/E ratio of 33.58 and a market capitalization of 60.3B. These metrics, combined with our AI analysis, provide a comprehensive view for both institutional and retail investors.

1-Day Change
0.54%
5-Day Change
4.92%
1-Month Change
12.35%
3-Month Change
9.42%
6-Month Change
14.69%
Year-to-Date (YTD) Change
13.57%
1-Year Change
67.78%
3-Year Change
247.54%
5-Year Change
211.83%
All-Time (Max) Change
958.13%

Contact Information

32 2 559 99 99
Allée de la Recherche, 60, Brussels, NaN, 1070

Company Facts

9,052 Employees
IPO DateAug 3, 2012
CountryBE
Actively Trading

Frequently Asked Questions